πŸ‡ΊπŸ‡Έ FDA
Patent

US 7368578

Five-membered heterocyclic compounds

granted A61PA61P3/04A61P3/06

Quick answer

US patent 7368578 (Five-membered heterocyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P3/04, A61P3/06, A61P3/10, A61P43/00